Google DeepMind researchers have introduced AlphaGenome 2, an AI model designed to analyze how DNA changes impact different cells. This new model provides a more granular understanding of genetic variations, which is crucial for identifying disease causes and potential treatments. It builds upon the original AlphaGenome model released last year.
While all human cells share the same DNA, gene expression varies significantly across different cell types and states. These variations mean a single genetic variant can have diverse effects depending on the cell. AlphaGenome 2 is specifically designed to capture these differences, predicting the impact of genetic variants on individual cell types and their current states. This capability offers a more detailed perspective than broader models, potentially uncovering subtle disease-related effects in specific cells.
AlphaGenome 2 was trained using over 100 million individual cell profiles sourced from 68 different tissues. This extensive training data allows the model to transform static cell atlases into a predictive tool for human genetics. DeepMind reports that AlphaGenome 2 can identify almost twice as many variants that alter gene expression in cells compared to its previous state-of-the-art model.
A notable feature of AlphaGenome 2 is its ability to make predictions about new cell types and biological states without requiring retraining. The model can also pinpoint gaps in existing experimental data, which could guide scientists in planning future laboratory investigations. Researchers involved in the project highlight its significance in connecting human genetics with cell biology, enabling a deeper dive into genetic variants identified in large populations.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
Google DeepMind has released AlphaGenome 2, an AI model that predicts how genetic mutations affect specific cell types and states. This model offers a more detailed view than previous versions, potentially revealing disease-relevant effects that were previously undetectable. AlphaGenome 2 identifies nearly twice as many gene expression-altering variants compared to its predecessor.